The content on this site is intended for healthcare professionals only
Rare cancers and the difficulties in making clinical decisions
Published: 27 Sep 2014
Views: 2317
Dr Paolo Casali - National Tumour Institute, Milan, Italy
At a press conference at ESMO 2014, Dr Casali addresses the challenges of taking clinical decisions in rare cancers.
Related Videos
CheckMate 9ER: aRCC patients on nivolumab plus cabozantinib achieved deeper resp...
Dr Cristina Suarez - Vall d’Hebron University Hospital, Catalonia, Spain
6 Jun 2022
Ibrutinib improves PFS by 50% for older patients with newly diagnosed mantle cel...
Dr Michael Wang - MD Anderson Cancer Center, Houston, USA
4 Jun 2022
AORTIC 2021: Goals of AORTIC
Dr Verna Vanderpuye - AORTIC 2021 Programme Director, Ghana
21 Oct 2021
Long term outcome of enfortumab vedotin + pembrolizumab in first line locally ad...
Dr Terence Friedlander - UCSF, San Francisco, USA
4 Jun 2021
Latest in EGFR-positive NSCLC with exon 20 insertion mutations
Prof Sanjay Popat, Prof Michael Thomas, Dr Marina Garassino, Dr Rosario Campelo,...
9 Feb 2021
Why overall survival is still the gold standard end point
Dr Bishal Gyawali - Queen's University, Kingston, Canada
13 Jan 2021
What is global oncology and what is the presence of global oncology in Europe
Prof Cristina Stefan - Institute of Oncology 'Prof Dr Alexandru Trestioreanu', B...
12 Oct 2020
ESMO 2020 melanoma roundup
Dr Teresa Amaral - University Hospital Tübingen, Tübingen, Germany
28 Sep 2020
Ensuring quality care for breast cancer patients globally
Dr Didier Verhoeven - University of Antwerp, Antwerp, Belgium
1 Jun 2020